Cointime

  • News
  • Insight
  • Currencies
  • Columns
  • Events
  • Bitcoin $114,942.44 +1.15%
  • Ethereum $4,201.35 +3.25%
  • BNB $1,144.23 +1.51%
  • Optimism $0.46 -0.11%
  • Arbitrum $0.34 +2.37%
  • Solana $200.21 +0.77%
  • Polygon $0.22 +2.77%
  • Cosmos $3.21 -0.51%
  • Avalanche $20.60 +1.61%
  • Bitcoin $114,942.44 +1.15%
  • Ethereum $4,201.35 +3.25%
  • BNB $1,144.23 +1.51%
  • Optimism $0.46 -0.11%
  • Arbitrum $0.34 +2.37%
  • Solana $200.21 +0.77%
  • Polygon $0.22 +2.77%
  • Cosmos $3.21 -0.51%
  • Avalanche $20.60 +1.61%
Home / Eikon Therapeutics / investors

Eikon Therapeutics

company

Investors

Number of Lead Investors
Number of Investors
1
18
Eikon Therapeutics is funded by 18 investors. Abu Dhabi Investment Authority and AME Cloud Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Abu Dhabi Investment Authority - Series B
AME Cloud Ventures - Series B
Canada Pension Plan Investment Board - Series B
E15 VC - Series B
EcoR1 Capital - Series B
Foresite Capital - Series B
General Catalyst - Series B
Harel Insurance Investments and Financial Services - Series B
Hartford HealthCare Endowment - Series B
Horizons Ventures - Series B
Innovation Endeavors - Series B
Lux Capital - Series B
Schroders Capital - Series B
Soros Capital Management - Series B
StepStone Group - Series B
T. Rowe Price - Series B
The Column Group - Series B
UC Investments - Series B

Contact

Hayward,California,United States
Cointime
Insight
  • Latest News
  • Web3
  • Blockchain
  • Metaverse
  • Bitcoin
  • Ethereum
  • NFT
  • DeFi
Features
  • Startups
  • Research
  • Technology
  • Topics
  • Columns
  • Currencies
  • Events
  • Tags
RSS
  • Latest News
  • Startups
  • Research
  • Technology
Company
  • About
  • Advertise
  • Disclaimers
  • © 2023 Cointime. All rights reserved.
  • Privacy Policy
  • Terms & Conditions